Investing News NetworkYour trusted source for investing success

Videos
Companies
Press Releases
Top Stocks
Top Resource Stocks
Top Tech Stocks
Top Life Science Stocks
Private Placements
Trending
Trending Articles

How Would a New BRICS Currency Affect the US Dollar? (Updated 2025)

10 Top Oil-producing Countries

What Was the Highest Price for Gold?

Top 10 Potash Countries by Production

13 Canadian Crypto ETFs (Updated 2025)

Could the Silver Price Really Hit $100 per Ounce?

Will Trump Bring Back the Gold Standard?

Rare Earths Reserves: Top 8 Countries

International Investing: How to Diversify with a Global Portfolio

Trending Press Releases

Critical Metals Corp. Enters Into Share Subscription Facility For Up To US$125.0M In Transaction Funding

Heliostar Delivers Strong Shallow Oxide Gold Hits at the La Colorada Mine, Sonora, Mexico

Quarterly Report for the 3 Months ended 31 December 2024

CY25 Production Program Underway, First Gold Pour in March

First Helium Spuds 7-15 Exploration Well

Energy Technologies Limited 2Q FY2025 Quarterly Activities Report and Appendix 4C

More Press Releases
Trending Companies

First Helium

HELI:CA

Radisson Mining Resources

RDS:CC

Nuclear Fuels

NF:CC

Soma Gold Corp.

SOMA:CA
More Companies
Trending Reports

Rare Earths Outlook Report

World Nickel Outlook 2025

2025 Gold Outlook Report

Nickel Investor Report

More Outlook Reports
Resource
Resource
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Tech
Tech
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Life Science
Life Science
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Gold Price
Silver Price
Copper Price
Oil Price
Uranium
Artificial Intelligence

Pharmaceutical Investing: World

Coverage of the pharma market for global investors, including news, analysis forecasts, and stock updates.

Scientist with petri dish.
Pharmaceutical Investing

Pharma Market Forecast: Top Trends for Pharma in 2025

Explore the key trends poised to shape the pharmaceutical industry in 2025, from breakthroughs in research and development to regulatory changes.

pharmaceutical investingpharmaceutical outlookpharmaceutical stocksPharmaceutical Investing
Latest Articles

Johnson & Johnson to Expand Neuroscience Portfolio with US$14.6 Billion Acquisition

pharmaceutical stocksm&apharmaceutical investingPharmaceutical Investing

Top 5 Small-cap Pharma Stocks (Updated January 2025)

best performing stockspharmaceutical stockspharmaceutical investingPharmaceutical Investing

5 Best-performing Canadian Pharma Stocks (Updated January 2025)

united statespharmaceutical stockscanadapharmaceutical investingcse stocksPharmaceutical Investing

5 Biggest Pharma Stocks

pharmaceutical investingpharmaceutical stocksPharmaceutical Investing

Top 5 Life Science ETFs in 2024

biotech stocksbiotech investingpharmaceutical investingpharmaceutical stocksBiotech Investing

5 Biggest Pharmaceutical ETFs

pharmaceutical investingpharmaceutical stocksPharmaceutical Investing
Company Profiles
SBM:CA

Sirona Biochem

Advanced chemistry platform for commercial opportunities in cosmetics and pharmaceuticals

biotech investingpharmaceutical investingtsxv:sbmBiotech Investing

Fungtional Labs

Integrated supply chain for mushroom cultivators in North America

pharmaceutical investingpsychedelics investingPharmaceutical Investing
CRDL:CA

Cardiol Therapeutics

Heal the heart with innovative science.

biotech stockspharmaceutical investingtsx:crdlPharmaceutical Investing
} More Companies
CEO Interviews

Sirona Biochem Eyes 2025 Launch of New Anti-aging Product

pharmaceutical investingtsxv:sbmbiotech investingBiotech Investing

"Wrap-around Care" Model Helps Address Gaps in Mental Healthcare

pharmaceutical investingpharmaceutical stockscannabis investingPharmaceutical Investing

Orphan Drug Development an Exciting Opportunity to Provide Superior Therapeutics, Lobe Sciences CEO Says

pharmaceutical investingcse:lobecse stockspsychedelics investingPharmaceutical Investing
Trending

Big Pharma Stocks Eli Lilly, AbbVie and Pfizer Share Q3 Results

pharmaceutical investingpharmaceutical stocksPharmaceutical Investing

4 Best-performing Canadian Pharma Stocks (Updated October 2024)

pharmaceutical investingpharmaceutical stocksPharmaceutical Investing

Harris vs. Trump: The 2024 US Election, Drug Prices and Healthcare

pharmaceutical stockspharmaceutical investingpharmaceutical outlookPharmaceutical Investing
pharmaceutical News
Cardiol Therapeutics (TSX:CRDL)

Cardiol Therapeutics to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference

Biotech Investing
Sirona Biochem (TSXV:SBM)

Sirona Biochem Showcases TFC-1326 in Stonegate Healthcare's Landmark Report

Biotech Investing
Cardiol Therapeutics (TSX:CRDL)

PRISM MarketView Features Q&A with President and CEO David Elsley: Cardiol Therapeutics Enters Phase 3 Clinical Trial for CardiolRx Addressing Patients with Recurrent Pericarditis

Biotech Investing

Invion Doses First Patient in Phase I/II Non-Melanoma Skin Cancer Trial

life science investing
Sirona Biochem (TSXV:SBM)

Sirona Biochem Announces Publication of Groundbreaking Study on TFC-1326 Compound in the Journal of Cosmetic Dermatology

Biotech Investing
Cardiol Therapeutics (TSX:CRDL)

Cardiol Therapeutics' Phase II MAvERIC-Pilot Clinical Results in Recurrent Pericarditis Presented at the American Heart Association Scientific Sessions 2024

Biotech Investing

ISLA-101 Phase 2a/b PROTECT Clinical Trial Progress Update

life science investing
Cardiol Therapeutics (TSX:CRDL)

Cardiol Therapeutics Inc. Added to PRISM Emerging Biotech Index

Biotech Investing

Interim Data from Accent Pancreatic Cancer Trial Supports Continuation of Trial

Life Science Investing
Cardiol Therapeutics (TSX:CRDL)

Cardiol Therapeutics to Advance CardiolRx into a Late-Stage Trial in Patients with Recurrent Pericarditis

Biotech Investing

InhaleRx Secures $38,500,000 Funding to Fully Fund Clinical Development Plans

life science investing

Invion Limited Notification of Security Consolidation or Split

Pharmaceutical Investing
Cardiol Therapeutics (TSX:CRDL)

Cardiol Therapeutics Announces Exercise and Closing of Over-Allotment Option

Biotech Investing
Cardiol Therapeutics (TSX:CRDL)

Cardiol Therapeutics Announces Closing of US$13.5 Million Public Offering of Common Shares

Biotech Investing
Cardiol Therapeutics (TSX:CRDL)

Cardiol Therapeutics Announces Pricing of Public Offering of Common Shares

Biotech Investing
More pharmaceutical News
Editors' Picks
Biotech Investing

How Big Tech is Helping Leverage Big Data in Healthcare

Pharmaceutical Investing

Pharma Market Forecast: Top Trends That Will Affect Pharma in 2024

Pharmaceutical Investing

Pharma Market Forecast: 3 Top Trends That Will Affect Pharma in 2023

Latest pharmaceutical News

More pharmaceutical News
×